Silencing NF-κB expression inhibited the upregulation of GM-CSF in hypoxic conditions (Fig. 4b–d), suggesting that hypoxic tumour cells upregulate GM-CSF expression through the activation of NF-κB signalling. This evidence concerns the gene CSF2 and neoplasm.